Manufacturing Execution System in Biopharma Industry: Global Growth Outlook to 2033
The Manufacturing Execution System (MES) in the life sciences market is poised for significant growth by 2033, driven by the increasing need for operational efficiency, regulatory compliance, and enhanced product quality. MES acts as a critical bridge between enterprise resource planning (ERP) systems and the manufacturing floor, facilitating real-time data collection and analysis. This...
0 Comments 0 Shares 19 Views 0 Reviews